Cargando…
A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection
BACKGROUND: Cardiovascular complications of the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), have been documented both in the acute phase and in convalescence. One such complication is the formation of the left ventricular...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Whioce Publishing Pte. Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715711/ https://www.ncbi.nlm.nih.gov/pubmed/34988332 |
_version_ | 1784624183924228096 |
---|---|
author | Philip, Anil Mathew George, Lina James John, Kevin John George, Anu Anna Nayar, Jemimah Sahu, Kamal Kant Selvaraj, Vijairam Lal, Amos Mishra, Ajay Kumar |
author_facet | Philip, Anil Mathew George, Lina James John, Kevin John George, Anu Anna Nayar, Jemimah Sahu, Kamal Kant Selvaraj, Vijairam Lal, Amos Mishra, Ajay Kumar |
author_sort | Philip, Anil Mathew |
collection | PubMed |
description | BACKGROUND: Cardiovascular complications of the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), have been documented both in the acute phase and in convalescence. One such complication is the formation of the left ventricular (LV) thrombus. There is a lack of clarity regarding the incidence, risk factors, and management of this complication. AIM: The aim of the study is to identify the clinical presentation, risk factors and outcome of COVID-19 patients with left ventricular thrombus (LVT). METHODS: A literature search was conducted to identify all case reports of COVID-19 with LVT in PubMed/Medline, Embase, Web of Science, and Google Scholar. RESULTS: Among the 65 patients identified, 60 had LVT, either at admission, or during the acute phase of the illness. Six patients with mild symptoms during the acute phase of viral illness had only the COVID-19 antibody test positivity at the time LV thrombus was detected. Few of the patients (23.1%) had no comorbidities. The mean age of the patients was 52.8 years, and the youngest patient was 4 years old. This suggests that LVT formation can occur in young COVID-19 patients with no co-morbid conditions. Most of the patients (69.2%) had more than one site of thrombosis. A mortality rate of 23.1% was observed in our review, and ST-elevation myocardial infarction (STEMI) was diagnosed in 33.3% of those who died. CONCLUSIONS: A high degree of suspicion for LVT must be maintained in patients with known cardiac disease and those with new-onset arterial or venous thromboembolism, and such patients may benefit from a screening echocardiography at admission. RELEVANCE FOR PATIENTS: The patients with preexisting cardiovascular disease must take added precautions to prevent acquiring COVID-19 infection as there is a higher risk of developing LV thrombus. In patients who develop LVT in COVID-19, mortality rate is higher. |
format | Online Article Text |
id | pubmed-8715711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Whioce Publishing Pte. Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87157112022-01-04 A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection Philip, Anil Mathew George, Lina James John, Kevin John George, Anu Anna Nayar, Jemimah Sahu, Kamal Kant Selvaraj, Vijairam Lal, Amos Mishra, Ajay Kumar J Clin Transl Res Review Article BACKGROUND: Cardiovascular complications of the coronavirus disease 2019 (COVID-19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), have been documented both in the acute phase and in convalescence. One such complication is the formation of the left ventricular (LV) thrombus. There is a lack of clarity regarding the incidence, risk factors, and management of this complication. AIM: The aim of the study is to identify the clinical presentation, risk factors and outcome of COVID-19 patients with left ventricular thrombus (LVT). METHODS: A literature search was conducted to identify all case reports of COVID-19 with LVT in PubMed/Medline, Embase, Web of Science, and Google Scholar. RESULTS: Among the 65 patients identified, 60 had LVT, either at admission, or during the acute phase of the illness. Six patients with mild symptoms during the acute phase of viral illness had only the COVID-19 antibody test positivity at the time LV thrombus was detected. Few of the patients (23.1%) had no comorbidities. The mean age of the patients was 52.8 years, and the youngest patient was 4 years old. This suggests that LVT formation can occur in young COVID-19 patients with no co-morbid conditions. Most of the patients (69.2%) had more than one site of thrombosis. A mortality rate of 23.1% was observed in our review, and ST-elevation myocardial infarction (STEMI) was diagnosed in 33.3% of those who died. CONCLUSIONS: A high degree of suspicion for LVT must be maintained in patients with known cardiac disease and those with new-onset arterial or venous thromboembolism, and such patients may benefit from a screening echocardiography at admission. RELEVANCE FOR PATIENTS: The patients with preexisting cardiovascular disease must take added precautions to prevent acquiring COVID-19 infection as there is a higher risk of developing LV thrombus. In patients who develop LVT in COVID-19, mortality rate is higher. Whioce Publishing Pte. Ltd. 2021-11-06 /pmc/articles/PMC8715711/ /pubmed/34988332 Text en Copyright: © Whioce Publishing Pte. Ltd. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Philip, Anil Mathew George, Lina James John, Kevin John George, Anu Anna Nayar, Jemimah Sahu, Kamal Kant Selvaraj, Vijairam Lal, Amos Mishra, Ajay Kumar A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection |
title | A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection |
title_full | A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection |
title_fullStr | A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection |
title_full_unstemmed | A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection |
title_short | A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection |
title_sort | review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715711/ https://www.ncbi.nlm.nih.gov/pubmed/34988332 |
work_keys_str_mv | AT philipanilmathew areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT georgelinajames areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT johnkevinjohn areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT georgeanuanna areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT nayarjemimah areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT sahukamalkant areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT selvarajvijairam areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT lalamos areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT mishraajaykumar areviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT philipanilmathew reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT georgelinajames reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT johnkevinjohn reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT georgeanuanna reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT nayarjemimah reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT sahukamalkant reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT selvarajvijairam reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT lalamos reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection AT mishraajaykumar reviewofthepresentationandoutcomeofleftventricularthrombusincoronavirusdisease2019infection |